Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Lewis

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1971
Pyrazolopyrimidine nucleosides. Part II. 7-Substituted 3- -D-ribofuranosylpyrasolo(4,3-d)pyrimidines related to and derived from the nucleoside antibiotics formycin and formycin BR A Long, A F Lewis, R K Robins, et al.
The Journal of Biological Chemistry|October 18, 1996
Biochemical and biophysical properties of the core-binding factor alpha2 (AML1) DNA-binding domainB E Crute, A F Lewis, Z Wu, et al.
Journal of Virology|May 1, 1995
Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer coresA L Zaiman, A F Lewis, B E Crute, et al.
Journal of Virology|June 11, 1999
Core-binding factor influences the disease specificity of Moloney murine leukemia virusA F Lewis, T Stacy, W R Green, et al.
Biochemical Pharmacology|May 1, 1979
N-Methylformycins. Reactivity with adenosine deaminase, incorporation into intracellular nucleotides of human erythrocytes and L 1210 cells and cytotoxicity to L 1210 cellsG W Crabtree, R P Agarwal, R E Parks, et al.
Antisense & Nucleic Acid Drug Development|November 15, 1997
Sequence-specific inhibition of the tumor necrosis factor-alpha receptor I gene by oligodeoxynucleotides containing N7 modified 2'-deoxyguanosineJ O Ojwang, A F Lewis, G R Revankar, et al.
Journal of Medicinal Chemistry|January 1, 1990
Synthesis and in vivo antitumor activity of 2-amino-9H-purine-6-sulfenamide, -sulfinamide, and -sulfonamide and related purine ribonucleosidesG R Revankar, N B Hanna, N Imamura, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Inhibition of human cytomegalovirus in culture by alkenyl guanine analogs of the thiazolo[4,5-d]pyrimidine ring systemA F Lewis, J C Drach, S M Fennewald, et al.
Journal of Medicinal Chemistry|October 1, 1991
Synthesis and antiviral activity of certain guanosine analogues in the thiazolo[4,5-d]pyrimidine ring systemG D Kini, J D Anderson, Y S Sanghvi, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
Thiazolo[4,5-d]pyrimidines. Part II. Synthesis and anti-human cytomegalovirus activity in vitro of certain acyclonucleosides and acyclonucleotides derived from the guanine analogue 5-aminothiazolo[4,5-d]pyrimidine-2,7(3H,6H)-dioneG R Revankar, J O Ojwang, S D Mustain, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1971
Pyrazolopyrimidine nucleosides. Part II. 7-Substituted 3- -D-ribofuranosylpyrasolo(4,3-d)pyrimidines related to and derived from the nucleoside antibiotics formycin and formycin BR A Long, A F Lewis, R K Robins, et al.
The Journal of Biological Chemistry|October 18, 1996
Biochemical and biophysical properties of the core-binding factor alpha2 (AML1) DNA-binding domainB E Crute, A F Lewis, Z Wu, et al.
Journal of Virology|May 1, 1995
Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer coresA L Zaiman, A F Lewis, B E Crute, et al.
Journal of Virology|June 11, 1999
Core-binding factor influences the disease specificity of Moloney murine leukemia virusA F Lewis, T Stacy, W R Green, et al.
Biochemical Pharmacology|May 1, 1979
N-Methylformycins. Reactivity with adenosine deaminase, incorporation into intracellular nucleotides of human erythrocytes and L 1210 cells and cytotoxicity to L 1210 cellsG W Crabtree, R P Agarwal, R E Parks, et al.
Antisense & Nucleic Acid Drug Development|November 15, 1997
Sequence-specific inhibition of the tumor necrosis factor-alpha receptor I gene by oligodeoxynucleotides containing N7 modified 2'-deoxyguanosineJ O Ojwang, A F Lewis, G R Revankar, et al.
Journal of Medicinal Chemistry|January 1, 1990
Synthesis and in vivo antitumor activity of 2-amino-9H-purine-6-sulfenamide, -sulfinamide, and -sulfonamide and related purine ribonucleosidesG R Revankar, N B Hanna, N Imamura, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Inhibition of human cytomegalovirus in culture by alkenyl guanine analogs of the thiazolo[4,5-d]pyrimidine ring systemA F Lewis, J C Drach, S M Fennewald, et al.
Journal of Medicinal Chemistry|October 1, 1991
Synthesis and antiviral activity of certain guanosine analogues in the thiazolo[4,5-d]pyrimidine ring systemG D Kini, J D Anderson, Y S Sanghvi, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
Thiazolo[4,5-d]pyrimidines. Part II. Synthesis and anti-human cytomegalovirus activity in vitro of certain acyclonucleosides and acyclonucleotides derived from the guanine analogue 5-aminothiazolo[4,5-d]pyrimidine-2,7(3H,6H)-dioneG R Revankar, J O Ojwang, S D Mustain, et al.
Pageof 4